| Name | Metelimumab |
|---|
| Description | Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1[1]. |
|---|---|
| Related Catalog | |
| Target |
TGFβ1[1] |
| In Vitro | Metelimumab (0.5 pg/mL-50 μg/mL) 抑制 A549 细胞中 TGFβ1 刺激的 IL-11 产生[1]。 |
| References |
| No Any Chemical & Physical Properties |